Attachment: Product Information: Ambrisentan

pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD), in patients with WHO functional class II, III or IV symptoms. VOLIBRIS in combination with Tadalafil is indicated for the treatment of WHO Group 1 pulmonary arterial hypertension in patients with WHO functional class II, III or IV symptoms. ................
................